Cargando…
hESCs‐Derived Early Vascular Cell Spheroids for Cardiac Tissue Vascular Engineering and Myocardial Infarction Treatment
Transplanting functional cells to treat myocardial infarction (MI), a major disease threatening human health, has become the focus of global therapy. However, the efficacy has not been well anticipated, partly due to the lack of microvascular system that supplies nutrients and oxygen. Here, spheroid...
Autores principales: | Liu, Yang, Zhang, Yifan, Mei, Tianxiao, Cao, Hao, Hu, Yihui, Jia, Wenwen, Wang, Jing, Zhang, Ziliang, Wang, Zhan, Le, Wenjun, Liu, Zhongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948571/ https://www.ncbi.nlm.nih.gov/pubmed/35092352 http://dx.doi.org/10.1002/advs.202104299 |
Ejemplares similares
-
Hyaluronate supports hESC‐cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction
por: Tan, Yuanqing, et al.
Publicado: (2020) -
Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction
por: Ye, Jianqin, et al.
Publicado: (2015) -
hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts
por: Todorova, Dilyana, et al.
Publicado: (2020) -
Homozygous MESP1 knock-in reporter hESCs facilitated cardiovascular cell differentiation and myocardial infarction repair
por: Wang, Lin, et al.
Publicado: (2020) -
Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies
por: Ji, Tian‐Tian, et al.
Publicado: (2023)